Study withdrawn: no participants enrolled to explore cancer genetics
NCT ID NCT06283238
First seen Jan 30, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study aimed to look at genetic changes in gastroesophageal cancer that might help explain why some patients do not respond to immunotherapy. It was an observational study, meaning no treatment or drugs were given. Participants would have provided blood and tumor samples before starting their standard cancer care. The study was withdrawn before enrolling anyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.